Evidence map›Paper›PMID 39317190›Full record

ArticleCell reports. Medicine2024

Pig-to-human kidney xenotransplants using genetically modified minipigs.

Yi Wang, Gang Chen, Dengke Pan, Hui Guo, Hongtao Jiang, Jianli Wang, Hao Feng, Songzhe He, Jiaxiang Du, Man Zhang and 19 more

Abstract read
In one paragraph

Article in Cell reports. Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Transgenic expression of human CD47 on pig cells provides only partial protection against human macrophage-mediated destruction in human immune system mice.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  10. Xenotransplantation in Nephrology: A Narrative Review.Journal of personalized medicine · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Yi WangThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China. Electronic address: wayne0108@126.com.
Gang ChenInstitute of Organ Transplantation, Tongji Medical College; Key Laboratory of Organ Transplantation; Ministry of Education, NHC Key Laboratory of Organ Transplantation, Chinese Academy of Medical Science, Huazhong University of Science and Technology, Wuhan, China.
Dengke PanChengdu Clonorgan Biotechnology Co., Ltd, Chengdu, China.
Hui GuoInstitute of Organ Transplantation, Tongji Medical College; Key Laboratory of Organ Transplantation; Ministry of Education, NHC Key Laboratory of Organ Transplantation, Chinese Academy of Medical Science, Huazhong University of Science and Technology, Wuhan, China.
Hongtao JiangThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Jianli WangThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Hao FengInstitute of Organ Transplantation, Tongji Medical College; Key Laboratory of Organ Transplantation; Ministry of Education, NHC Key Laboratory of Organ Transplantation, Chinese Academy of Medical Science, Huazhong University of Science and Technology, Wuhan, China.
Songzhe HeThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Jiaxiang DuChengdu Clonorgan Biotechnology Co., Ltd, Chengdu, China.
Man ZhangInstitute of Organ Transplantation, Tongji Medical College; Key Laboratory of Organ Transplantation; Ministry of Education, NHC Key Laboratory of Organ Transplantation, Chinese Academy of Medical Science, Huazhong University of Science and Technology, Wuhan, China.
Tao LiThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Yong WangChengdu Clonorgan Biotechnology Co., Ltd, Chengdu, China.
Hang YuThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Huiling GanThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Quan WenThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Zhian SongThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Desheng LiThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Yifan YuThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Huanliang WangThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Bing LiThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Yong YouThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Shen ZhouThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Mingfa WangThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Lili LiuThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Liang XuThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Meng YangThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Hua PeiThe Second Affiliated Hospital and the Transplantation Institute, Hainan Medical University, Hainan, China.
Kang ZhangInstitute for AI in Medicine and Faculty of Medicine, Macau University of Science and Technology, Macau, China. Electronic address: kang.zhang@gmail.com.
Zhonghua K ChenInstitute of Organ Transplantation, Tongji Medical College; Key Laboratory of Organ Transplantation; Ministry of Education, NHC Key Laboratory of Organ Transplantation, Chinese Academy of Medical Science, Huazhong University of Science and Technology, Wuhan, China. Electronic address: zc104126@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study develops an observational model to assess kidney function recovery and xenogeneic immune responses in kidney xenotransplants, focusing on gene editing and immunosuppression. Two brain-dead patients undergo single kidney xenotransplantation, with kidneys donated by minipigs genetically modified to include triple-gene knockouts (GGTA1, β4GalNT2, CMAH) and human gene transfers (hCD55 or hCD55/hTBM). Renal xenograft functions are fully restored; however, immunosuppression without CD40-CD154 pathway blockade is ineffective in preventing acute rejection by day 12. This rejection manifests as both T cell-mediated rejection and antibody-mediated rejection (AMR), confirmed by natural killer (NK) cell and macrophage infiltration in sequential xenograft biopsies. Despite donor pigs being pathogen free before transplantation, xenografts and recipient organs test positive for porcine cytomegalovirus/porcine roseolovirus (PCMV/PRV) by the end of the observation period, indicating reactivation and contributing to significant immunopathological changes. This study underscores the critical need for extended clinical observation and comprehensive evaluation using deceased human models to advance xenograft success.

Indexed as

Animals, Genetically ModifiedGalactosyltransferasesGraft RejectionKidney TransplantationSwine, MiniatureTransplantation, HeterologousAnimalsHeterograftsHumansKidneyKiller Cells, NaturalSwinealpha-1,3-galactosyltransferase 1, porcineGalactosyltransferasesacute xenograft rejectionbrain-dead human decedentgenetically engineered pigkidney transplantationPCMV/PRVxenotransplantation

Identifiers

PMID39317190
PMCPMC11513830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.